Ligand Pharmaceuticals Payables and Accrued Expenses (Quarterly) Analysis

Ligand Pharmaceuticals, Inc. (LGND)

201.15 -2.67 (-1.31%) USD | NASDAQ | Jan 23, 16:00

201.06 -0.09 (-0.04%) After-Hours: 20:00

View Payables and Accrued Expenses (Quarterly) for LGND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial